Liquid biopsy in pancreatic cancer: the beginning of a new era

With dismal survival rate pancreatic cancer remains one of the most aggressive and devastating malignancy. Predominantly, due to the absence of a dependable methodology for early identification and limited therapeutic options for advanced disease. However, it takes over 17 years to develop pancreati...

Descripción completa

Detalles Bibliográficos
Autores principales: Yadav, Dipesh Kumar, Bai, Xueli, Yadav, Rajesh Kumar, Singh, Alina, Li, Guogang, Ma, Tao, Chen, Wei, Liang, Tingbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6003564/
https://www.ncbi.nlm.nih.gov/pubmed/29928492
http://dx.doi.org/10.18632/oncotarget.24809

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6003564/
https://www.ncbi.nlm.nih.gov/pubmed/29928492
http://dx.doi.org/10.18632/oncotarget.24809

Ejemplares similares